The clarification from the German biotech company comes on the heels of a Bloomberg report that Pfizer is considering selling ...

BioNTech (NASDAQ:BNTX) pushed back on speculation Thursday that Pfizer (NYSE:PFE) may be preparing to unload its stake in the ...

BioNTech (NasdaqGS:BNTX) shares caught investors’ attention after Pfizer revealed plans to sell its remaining stake in the company through an overnight block trade. This announcement prompted a wave ...

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...

Analysts' ratings for BioNTech (NASDAQ:BNTX) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The following table summarizes their recent ratings, shedding light on the ...

Market researchers at HC Wainwright & Co. have increased their outlook on BioNTech, raising their price target from $136 to $140 while maintaining their "Buy" recommendation. This upgraded assessment ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Investing.com -- BioNTech has raised its full-year 2025 revenue guidance following initial payments from its new partnership with Bristol Myers Squibb in a cancer immunotherapy alliance aimed at ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Sunday 9 November 2025 marks the fifth anniversary of a defining moment in stock market history. Pfizer/BioNTech’s ...

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...

[NEW YORK] Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the ...